|Carnegie Science Center hosted the 21st Annual Carnegie Science Awards at the Carnegie Music Hall, where John graciously accepted his well-deserved award. He was amended for his innovative & influential research on acute kidney injury. John has been a leader in the effort to increase understanding, establish diagnostics & therapeutics, and improve the quality of care for these critically ill patients.
The Center for Critical Care Nephrology was pleased to host Dr. Sean Bagshaw for the 6th annual AKI Symposium. While in Pittsburgh, Dr. Bagshaw presented ‘Frailty in Critical Illness’ at Grand Rounds. After his lecture on this relevant topic, he joined the C3N group for brief research presentations. Faculty discussed the groundbreaking research developments with Dr. Bagshaw and engaged in refreshing dialogue regarding nephrology. During the AKI Symposium, as a keynote lecturer, Dr. Bagshaw presented ‘Strategies for When to Start Renal Replacement Therapy in Acute Kidney Injury’. This intriguing topic led to a group discussion, where Dr. Bagshaw and other experts fielded audience questions and elaborated on complex themes in critical care nephrology. We graciously anticipate further discussions and working with Dr. Bagshaw.
September 08, 2016
Dr. Murugan has been recently appointed as the ICU Director and Chief of Critical Care Medicine of Magee Women’s hospital of UPMC. The Magee 14-bed state of the art unit admits critically ill patients from Internal Medicine and related sub-specialties, Obstetrics, Gynecology and Oncology services as well as General, Bariatric, Gynecologic/Oncology, Urology, Orthopedic, Breast and ENT surgical services. In addition to his current responsibility Dr. Murugan has also been appointed as the Director of the Rapid Response System at Presbyterian University Hospital that oversees more than 2000 rapid response team calls including approximately 150 activations for cardiopulmonary arrest.
Dr. Murugan is an Associate Professor in the Department of Critical Care Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh, School of Medicine. He is also currently an Attending Intensivist at the Abdominal Organ Transplant Intensive Care Unit at the University of Pittsburgh Medical Center. He is American Board certified in Internal Medicine and the subspecialty of Critical Care Medicine, and is an elected Fellow of the Royal College of Physicians, London, UK and the American College of Critical Care Medicine.
Dr. Murugan is a core faculty member of the Center for Critical Care Nephrology, CRISMA, and has authored more than 60 peer reviewed publications. He conducts translational research to understand mechanisms of inflammation-induced organ dysfunction after critical illness with a particular focus on acute kidney injury. Dr. Murugan is a recipient of the National Institute of Health’s (NIH) career development award. Dr. Murugan employs a highly innovative and paradigm shifting approaches from systems biology, biostatistics, bioengineering, epidemiology, biostatistics, and translational methods to understand complex dynamics of critical illness, develop hypotheses, and examine new therapies in critical illness.
May 01, 2016
Liyan Cui is going to be the Chair of her department at the Peking University Third Hospital. Here is a brief introduction of her department: The Department of Laboratory Medicine in Peking University third Hospital is now a modernized, multifunctional center for clinical laboratory, medical education and research. There are 6 branches including clinical biochemistry, clinical immunology, clinical microbiology, clinical hematology, clinical molecular biology and blood bank. 66 professional employees are now working in our department.
The department was equipped with advanced biomedical analytical instruments such as OLYMPUS AU5400 automatic analyzer, HITACHI 7170A automatic analyzer, Johnson & Johnson VITROS 250/950 automatic analyzer; SYSMEX XE2100 and SF3000 automatic hemacytometer, UF100 urine sediment analytical station, Beckman Coulter STKS, GEN.S auto hematology analyzer, ACL9000 & ACL200 auto blood coagulation analyzer, EPICS-XL flow cytometer and Array360 specific protein analyzer; Roche E170 & 2010 automatic electrochemiluminescent immunoanalyzer；Merieux VITEK2 auto microorganism station and Bact ALERT 3D auto-blood culture system；Abbott IMx & AxSYM auto immunoanalyzer, TDxFLx drug assay system，Sebia Hydrasys electrophoresis analyzer，TOSOH HLC-723G7 automated glycohemoglobin analyzer，ABI 5700 and Roche Lightcycler PCR amplifier.
Besides clinical work, our department participates in the EQA of Beijing and National Center for Clinical Laboratory for years. Our department takes the regular and special experiments for evaluation of curative effect and side-effects in the clinical trial (phase 2) under the supervision and inspection of related institution in Beijing city and State.